More OncoSil Medical Ltd news
OncoSil Medical LtdASX: OSL

Specialised Therapeutics Australia supporting OncoSil study

Apr 19, 2017 at 11:52 PM EDT · Issued by OncoSil Medical Ltd

Filed with ASX · Apr 19, 2017 at 11:52 PM EDT

On 6ix: 6ix.com/news/specialised-therapeutics-australia-supporting-oncosil-study

Oncosil Medical Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

  • US IRB Approval, MD Anderson Cancer CentreApr 18, 2017
  • UK Central Ethics ApprovalApr 4, 2017
  • First subject recruitedMar 27, 2017
  • Appendix 4D & Half Year AccountsFeb 22, 2017
  • MHRA Approval to commence study in UKFeb 12, 2017

Later from OncoSil Medical

  • First OncoSil Device Implantation procedure completedApr 25, 2017
  • Appendix 4C and Quarterly updateApr 26, 2017
  • Second subject recruited at Monash Health MelbourneMay 10, 2017
  • CE Mark & Quarterly Activity UpdateJul 30, 2017
  • First UK subject recruitedAug 21, 2017
All OncoSil Medical news releases↗

Follow OncoSil Medical into a list and get an email when it puts out news.

Follow OncoSil Medical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer